Analyze Diet

Topic:Equine Herpesvirus

Equine Herpesvirus (EHV) is a contagious virus that affects horses, causing a range of clinical conditions. It primarily impacts the respiratory system but can also lead to neurological disorders, abortion in pregnant mares, and neonatal foal death. The virus is transmitted through direct contact with infected horses or through contaminated surfaces and equipment. There are several strains of EHV, with Equine Herpesvirus-1 (EHV-1) and Equine Herpesvirus-4 (EHV-4) being the most commonly studied due to their prevalence and impact on equine health. EHV-1 is associated with more severe outcomes, including equine herpesvirus myeloencephalopathy (EHM). This page aggregates peer-reviewed research studies and scholarly articles that explore the epidemiology, pathogenesis, clinical manifestations, and management strategies related to Equine Herpesvirus in horses.
[Equine rhinopneumonitis: molecular epidemiology and diagnosis by molecular probes prepared from organs].
Revue scientifique et technique (International Office of Epizootics)    June 1, 1993   Volume 12, Issue 2 493-504 
Zientara S, Sailleau C.The authors briefly review the clinical forms of equine rhinopneumonitis and indicate changes in the nomenclature of equine herpesviral infections. The value of restriction profiles for epidemiological studies is described, taking as an example the strains of virus isolated in France. A technique is given for preparing molecular probes, as well as the application of these probes in direct diagnosis from biological specimens.
Responses of ponies to equid herpesvirus-1 ISCOM vaccination and challenge with virus of the homologous strain.
Research in veterinary science    May 1, 1993   Volume 54, Issue 3 299-305 doi: 10.1016/0034-5288(93)90126-z
Hannant D, Jessett DM, O'Neill T, Dolby CA, Cook RF, Mumford JA.An experimental (ISCOM) vaccine previously shown to protect hamsters from lethal challenge with equid herpesvirus-1 (EHV-1), was tested in horses. Vaccination with EHV-1 ISCOMs induced serum antibodies to the major virus glycoproteins gp10, 13, 14, 17, 18 and 21/22a, whereas antibody responses to gp2 were weak or absent. High levels of virus neutralising antibody of long duration were induced, but did not prevent challenge infection with virus of the homologous strain. However, in the vaccinated ponies there was a significant reduction in clinical signs, nasal virus excretion and cell associat...
Pathogenicity of a thymidine kinase-deficient mutant of equine herpesvirus 1 in mice and specific pathogen-free foals.
The Journal of general virology    May 1, 1993   Volume 74 ( Pt 5) 819-828 doi: 10.1099/0022-1317-74-5-819
Slater JD, Gibson JS, Field HJ.Both intranasal (i.n.) and intracerebral (i.c.) inoculation of mice with wild-type equine herpesvirus type 1 (wt EHV-1) caused clinical signs and mortality. Virus could be recovered from target organs (turbinates, lungs and blood) for several days. By contrast, the thymidine kinase (TK)-deficient deletion mutant PR1 produced markedly less clinical disease following both i.n. and i.c. inoculation, and, in particular, no mortality occurred. PR1 did, however, establish productive infections following either route of inoculation. High titres of virus were recovered from target organs although viru...
Equine herpesvirus type 1 neurological disease and enterocolitis in mature standardbred horses. Carman S, Nagy E, Caldwell D, van Dreumel TA.No abstract available
Immunoprecipitation of viral polypeptides of equid herpesvirus 1 and 4 by serum from experimentally infected ponies.
Veterinary microbiology    March 1, 1993   Volume 34, Issue 3 205-219 doi: 10.1016/0378-1135(93)90012-v
Ahmed SM, Broad SC, Edington N.Sera from two sibling groups of ponies experimentally infected with Equid herpesvirus 1 or 4 (EHV-1 or 4) were used to investigate which viral polypeptides (VPs) of EHV-1 and EHV-4 were recognised. Recognition was detected as early as 8 d.p.i. and thereafter. The polypeptides of EHV-1 (labelled with 35S-methionine) immunoprecipitated (IIP) by sera from both groups had Mr of 148, 138, 123, 117, 110, 77-79, 70, 55, 49-50, 47, 40 and 35-37 kDa respectively. Of these VP148K (VP9 nucleocapsid) gave the maximum precipitation, followed by 117 and 77-79 kDa. The latter were confirmed by monoclonal ant...
Replication of equid herpesvirus-1 in the vaginal tunics of colts following local inoculation.
Research in veterinary science    March 1, 1993   Volume 54, Issue 2 249-251 doi: 10.1016/0034-5288(93)90066-o
Smith KC, Tearle JP, Boyle MS, Gower SM, Mumford JA.Equid herpesvirus-1 (EHV-1; Ab4 isolate) was inoculated unilaterally into the cavum vaginale of four pony colts under general anaesthesia. The animals were monitored daily for evidence of scrotal or testicular swelling and euthanased electively on days 3, 4, 6 and 12 after infection. Detailed pathological examination of the male genital tract was carried out. In animals examined at days 3 and 4 after infection, replication of EHV-1 was detected bilaterally in mesothelial and endothelial cells of the parietal and visceral vaginal tunics. The mesothelial infection had resolved by day 12 after in...
Detection of antibodies against equine herpesvirus types 1 and 4 by using recombinant protein derived from an immunodominant region of glycoprotein B.
Journal of clinical microbiology    February 1, 1993   Volume 31, Issue 2 265-271 doi: 10.1128/jcm.31.2.265-271.1993
Sinclair R, Binns MM, Chirnside ED, Mumford JA.The N-terminal fragment comprising residues +1 to +50 (gB1-50) of equine herpesvirus type 1 (EHV-1) glycoprotein B was expressed as a glutathione S-transferase fusion protein in Escherichia coli. Recombinant gB1-50 (rgB1-50) was recognized in immunoblots by sera from rabbits immunized with EHV-1 and by convalescent-phase sera from horses with natural EHV-1 infections. An enzyme-linked immunosorbent assay (ELISA) for monitoring antibody levels against EHV-1 was developed by using rgB1-50, and its specificity was assessed with a panel of reference antisera against other equine viruses. A specifi...
The genome of equine herpesvirus type 2 harbors an interleukin 10 (IL10)-like gene.
Virus genes    February 1, 1993   Volume 7, Issue 1 111-116 doi: 10.1007/BF01702353
Rode HJ, Janssen W, Rösen-Wolff A, Bugert JJ, Thein P, Becker Y, Darai G.A gene was identified within the DNA sequences of the EcoRI DNA fragment N (4.3 kbp) of the genome of equine herpesvirus type 2 (EHV-2) coding for a protein (179 amino acid residues) homologous to the cytokine synthesis inhibitory factor (CSIF; interleukin 10) of the human and mouse, and to the Epstein-Barr virus (EBV) protein BCRF1. This finding is further significant evidence that the interleukin 10 (IL-10) and/or IL-10-like gene can indeed be present in the genomes of members of the herpesviral family.
An immunohistological study of the uterus of mares following experimental infection by equid herpesvirus 1.
Equine veterinary journal    January 1, 1993   Volume 25, Issue 1 36-40 doi: 10.1111/j.2042-3306.1993.tb02898.x
Smith KC, Whitwell KE, Mumford JA, Gower SM, Hannant D, Tearle JP.Twelve Welsh Mountain pony mares in late gestation were infected intranasally with EHV-1 (AB4 isolate) at dose rates from 10(3) to 10(7.3) TCID50. This resulted in 3 cases of paresis, at Days 9, 10 and 12 after inoculation, and 5 abortions, at Days 6, 9, 18, 19 and 20. Euthanasia was performed between Days 6 and 21, with collection of uterine specimens for histopathology, virus isolation and immunoperoxidase staining from the pregnant horn, non-pregnant horn and body. EHV-1 replication in endometrial vessels was detected as early as Day 6 and was maximal at Days 9-11, when widespread thrombois...
Use of an immunoperoxidase technique to detect equine herpesvirus-1 antigen in formalin-fixed paraffin-embedded equine fetal tissues. Schultheiss PC, Collins JK, Carman J.An indirect immunoperoxidase (IP) procedure using the avidin-biotin-peroxidase complex detection technique was developed to detect viral equine herpesvirus-1 (EHV-1) antigen in formalin-fixed paraffin-embedded tissues from aborted equine fetuses. The procedure was applied to liver, lung, and other tissues from 20 cases of confirmed or suspected EHV-1-induced abortions. Specific staining was observed in tissue sections from EHV-1-infected fetuses. Positive IP staining was present in tissues of 7 cases that were also positive by fluorescent antibody (FA) and virus isolation (VI) and that had typ...
A type-specific conformational epitope on the nucleocapsid of equid herpesvirus-1 and its use in diagnosis.
Archives of virology    January 1, 1993   Volume 132, Issue 1-2 133-144 doi: 10.1007/BF01309848
van de Moer A, Rice M, Wilks CR.A type-specific monoclonal antibody was produced by immunizing mice with purified equid herpesvirus-1 (EHV-1). The EHV-1 specific mAb reacted with all the EHV-1 strains tested so far by indirect ELISA, immunofluorescence, and immunoperoxidase tests. No reactions were detected with the EHV-4, EHV-2, or EHV-3 strains tested. The indirect immunofluorescence and immunoperoxidase tests showed that the nuclei of infected cells were predominantly stained by this mAb. Triton treatment of the virus and immunogold labeling experiments indicated that the nucleocapsid of EHV-1 was the target antigen of th...
Equine herpesvirus 5: comparisons with EHV2 (equine cytomegalovirus), cloning, and mapping of a new equine herpesvirus with a novel genome structure.
Virology    November 1, 1992   Volume 191, Issue 1 176-186 doi: 10.1016/0042-6822(92)90179-s
Agius CT, Nagesha HS, Studdert MJ.A new equine herpesvirus, provisionally designated equine herpesvirus 5 (EHV5; Browning and Studdert (1987) J. Gen. Virol. 68, 1441-1447), was examined for the degree of genomic difference from equine herpesvirus 2 (EHV2) by Southern hybridizations. EHV5 and EHV2 whole genomic DNA probes were highly specific for homologous DNA only, indicating that significant genomic difference exists between the two viruses. Restriction endonuclease analysis of EHV5 strain 2-141 (EHV5.2-141) revealed that the genome is 179 kb and exists as a single isomer. Clones representing 82% of the genome were obtained ...
Immune responses of specific pathogen free foals to EHV-1 infection.
Veterinary microbiology    October 1, 1992   Volume 32, Issue 3-4 215-228 doi: 10.1016/0378-1135(92)90146-k
Chong YC, Duffus WP.Four foals were raised under specific pathogen free (SPF) conditions. At 3 to 4 months of age, SPF foals and 1 other non-SPF foal were intranasally inoculated with equine herpes virus type 1 (EHV-1). Clinical signs included depression, fever, inappetence and intermittent coughing. Clinical recovery was complete by seven days but high titres of virus were detected in nasal mucus for at least 10 days after inoculation. Clinical illness was less severe in the non-SPF foal. Interferon was detected in the nasal mucus of all foals from 2 days post infection (dpi), persisting until 8 or 10 dpi. ELISA...
Serological evidence of equine herpesvirus type 1 (EHV-1) activity in polo horses in Nigeria.
Zentralblatt fur Veterinarmedizin. Reihe B. Journal of veterinary medicine. Series B    October 1, 1992   Volume 39, Issue 8 628-630 doi: 10.1111/j.1439-0450.1992.tb01214.x
Adeyefa CA.Serological evidence of Equine Herpes virus type 1 (EHV-1) activity in Polo horses in Nigeria is reported for the first time. Eighty-two percent of horses tested with known antigen had precipitating antibodies to EHV-1 while 43% of sera tested against antigen prepared from nasal discharges were positive suggesting that the virus was being excreted in the nasal discharges and probably acting as a source of infection for incontact animals as occurs in on-going acute infections. The result of this study indicates a high prevalence of EHV-1 activity among Polo horses in Nigeria and demonstrates th...
Chorioretinopathy associated with neuropathology following infection with equine herpesvirus-1.
The Veterinary record    September 12, 1992   Volume 131, Issue 11 237-239 doi: 10.1136/vr.131.11.237-a
Slater JD, Gibson JS, Barnett KC, Field HJ.No abstract available
Immunokinetics of equine herpesvirus 1 in donkey mares: suppression of secondary cell-mediated response.
Revue scientifique et technique (International Office of Epizootics)    September 1, 1992   Volume 11, Issue 3 901-908 doi: 10.20506/rst.11.3.636
Singh M, Charan S.To study the immunokinetics of equine herpesvirus 1 (EHV1), donkey mares were immunised with a laboratory strain of EHV1, or with recommended doses of Pneumabort-K vaccine (EHV1 Army 183 strain, formalin-inactivated, with an oil adjuvant) and a booster was given after three months. Humoral immune responses were studied by employing a virus neutralisation (VN) test. A leucocyte migration inhibition test (LMIT) was employed for the assay of cellular immune responses. The VN antibody titre reached 1:64 or 1:128 after primary immunisation and showed a marginal increase (1:256) after secondary immu...
Identification of equine herpesvirus 4 glycoprotein G: a type-specific, secreted glycoprotein.
Virology    September 1, 1992   Volume 190, Issue 1 143-154 doi: 10.1016/0042-6822(92)91200-e
Crabb BS, Nagesha HS, Studdert MJ.Equine herpesvirus 4 (EHV4) glycoproteins of M(r) 63K and 250K were identified in the supernatant of infected cell cultures. The 63K glycoprotein was type-specific; that is, it reacted with monospecific sera from horses that had been immunized or infected with EHV4, but not with monospecific sera from horses immunized or infected with EHV1, a closely related alphaherpesvirus. It was postulated that the secreted protein may be the homologue of similarly secreted glycoproteins of herpes simplex virus 2 glycoprotein G (HSV2 gG) and pseudorabies virus (PRV) gX, which is the homologue of HSV2 gG. T...
Rapid detection of equine herpesvirus type-1 antigens in nasal swab specimens using an antigen capture enzyme-linked immunosorbent assay.
Journal of virological methods    September 1, 1992   Volume 39, Issue 3 299-310 doi: 10.1016/0166-0934(92)90103-k
Sinclair R, Mumford JA.An antigen capture enzyme-linked immunosorbent assay (ELISA) was developed for the detection of equine herpesvirus type-1 (EHV-1) antigens in nasal swab specimens. The test was designed as a solid phase, amplified sandwich assay in which an EHV-1 specific monoclonal antibody was used to capture virus antigen and polyclonal antisera used to detect antigen bound to the test plates. Eight monoclonal antibodies were tested for their ability to capture virus antigen and one was selected for routine use. The sensitivity and specificity of the ELISA was compared with that of virus isolation using swa...
The activity of (S)-1-[(3-hydroxy-2-phosphonyl methoxy) propyl] cytosine (HPMPC) against equine herpesvirus-1 (EHV-1) in cell cultures, mice and horses.
Antiviral research    September 1, 1992   Volume 19, Issue 3 219-232 doi: 10.1016/0166-3542(92)90081-f
Gibson JS, Slater JD, Field HJ.The activity of the nucleotide analogue, (S)-1-[(3-hydroxy-2-phosphonyl methoxy) propyl] cytosine (HPMPC), against equine herpesvirus-1 (EHV-1) was tested in cell culture, mice and foals. The ED50 for plaque reduction was found to be 0.07 and 0.03 microgram/ml in RK-13 and EEL cells respectively. In mice, a single administration of HPMPC (20 mg/kg, s.c.) was very effective at reducing clinical signs and virus replication if given on the day before intranasal inoculation with EHV-1. Treatment on the day of infection or day 1 p.i. was less effective, but still significantly reduced clinical sign...
Equid herpesvirus abortion–another piece in the pathogenesis puzzle.
Equine veterinary journal    July 1, 1992   Volume 24, Issue 4 251-252 doi: 10.1111/j.2042-3306.1992.tb02826.x
Ostlund EN.No abstract available
The pathogenicity of Ab4p, the sequenced strain of equine herpesvirus-1, in specific pathogen-free foals.
Virology    July 1, 1992   Volume 189, Issue 1 317-319 doi: 10.1016/0042-6822(92)90707-v
Gibson JS, Slater JD, Field HJ.The sequencing of the genome of equine herpesvirus-1 (EHV-1) is reported in Elizabeth A. R. Telford, Moira S. Watson, Kathryn McBride, and Andrew J. Davison, 1992, Virology, 189, 304-316. The sequence was derived using a plaque-purified clone of EHV-1 strain Ab4 (designated Ab4p). To ensure that Ab4p shares the pathogenic characteristics of parental Ab4 (hereafter Ab4), both were inoculated intranasally into foals, specifically free from EHV-1 and EHV-4. Clinical signs, including rectal temperature, were similar for both viruses. In addition, nasal shedding of virus was observed over a 1- to 2...
Abortion of virologically negative foetuses following experimental challenge of pregnant pony mares with equid herpesvirus 1.
Equine veterinary journal    July 1, 1992   Volume 24, Issue 4 256-259 doi: 10.1111/j.2042-3306.1992.tb02830.x
Smith KC, Whitwell KE, Binns MM, Dolby CA, Hannant D, Mumford JA.From 1988 to 1991, 51 pregnant pony mares were challenged intranasally or by aerosol with an isolate of EHV-1 (AB4) originally recovered from a quadriplegic mare. This resulted in 32 abortions, occurring from 9 to 29 days after infection. In 14 of the early abortions (Days 9-14), EHV-1 was not demonstrated in the foetal tissues by virus isolation or immunostaining despite no other non-viral cause for the abortion being evident. Application of the polymerase chain reaction to foetal tissues from 9 of these cases also proved negative. One of the 14 mares was destroyed immediately after abortion,...
Natural killer cells in normal horses and specific-pathogen-free foals infected with equine herpesvirus.
Veterinary immunology and immunopathology    June 1, 1992   Volume 33, Issue 1-2 103-113 doi: 10.1016/0165-2427(92)90038-r
Chong YC, Duffus WP, Hannant D.Peripheral blood mononuclear cells (PBMC) from an adult horse and from foals demonstrated natural killer (NK)-type cytotoxicity against a range of xenogeneic and allogeneic cell targets. The human tumour cell line, Chang liver was consistently the most susceptible. Chang liver, rabbit kidney (RK-13), equine sarcoid (ES) and embryonic equine kidney (EEK) cells were more susceptible when presented to horse PBMC than monolayer cultures. Embryonic equine lung (EEL) and murine YAC-1 cells conversely, were more susceptible in a trypsinized state. Horse PBMC demonstrated higher levels of NK-type acti...
The molecular epidemiology of equine herpesvirus 1 (equine abortion virus) in Australasia 1975 to 1989.
Australian veterinary journal    May 1, 1992   Volume 69, Issue 5 104-111 doi: 10.1111/j.1751-0813.1992.tb07462.x
Studdert MJ, Crabb BS, Ficorilli N.The restriction endonuclease DNA fingerprints of 57 isolates of equine herpesvirus 1 (EHV1; equine abortion virus) from abortion, perinatal foal mortalities and encephalitis from 15 epidemics that occurred in Australasia between 1975 and 1989 were examined using the enzymes Bam HI, EcoRI and Bgl II. There was a remarkable degree of uniformity in the restriction patterns; mobility differences were observed in only 14 of 52 (27%) of the fragments. Twelve of these 14 fragments were located within the repeat structures that bracket the unique short region of the genome or were located at the left ...
Epizootiological aspects of type 1 and type 4 equine herpesvirus infections among horse populations.
The Journal of veterinary medical science    April 1, 1992   Volume 54, Issue 2 207-211 doi: 10.1292/jvms.54.207
Matsumura T, Sugiura T, Imagawa H, Fukunaga Y, Kamada M.The dissemination of equine herpesvirus types 1 (EHV-1) and 4 (EHV-4) among various horse populations in Japan was investigated through the isolation and typing of virus strains from horses with respiratory diseases. Type specific monoclonal antibody pools were used for the typing of isolates. The 42 strains of EHV-1 and 64 strains of EHV-4 were isolated from 4593 nasal swabs and/or blood plasma samples collected from 3326 horses during a period from 1979 to 1990. All the strains of EHV-1 were isolated from racehorses only and during the winter season exclusively, when the epizootic of respira...
The effects of equine rhinovirus, influenza virus and herpesvirus infection on tracheal clearance rate in horses. Willoughby R, Ecker G, McKee S, Riddolls L, Vernaillen C, Dubovi E, Lein D, Mahony JB, Chernesky M, Nagy E.The response of horses exposed to three common respiratory viruses was studied by measuring tracheal mucociliary clearance rates in the trachea. Tracheal clearance rates (TCR) were determined before, during illness and following recovery in horses exposed to equine rhinovirus (ERhV-2), equine influenza virus (EIV) and equine herpesvirus (EHV-4) by means of lateral scintigraphs made following an injection of technetium-99m sulphide colloid into the tracheal lumen. In six horses exposed to ERhV-2, TCR remained within normal limits. Exposure to EIV resulted in reduced TCR in six of seven horses, ...
Vaccination of mares against equine herpesvirus-1.
The Veterinary record    March 7, 1992   Volume 130, Issue 10 211-212 doi: 10.1136/vr.130.10.211-c
Wood JL.No abstract available
Vaccination of mares against equine herpesvirus-1.
The Veterinary record    February 22, 1992   Volume 130, Issue 8 167-168 doi: 10.1136/vr.130.8.167-a
Pickles AC.No abstract available
Characterization of the regulatory functions of the equine herpesvirus 1 immediate-early gene product.
Journal of virology    February 1, 1992   Volume 66, Issue 2 936-945 doi: 10.1128/JVI.66.2.936-945.1992
Smith RH, Caughman GB, O'Callaghan DJ.Use of the translation-inhibiting drug cycloheximide has indicated that the equine herpesvirus 1 (EHV-1) immediate-early (IE) gene, the sole EHV-1 IE gene, encodes a major viral regulatory protein since IE mRNA translation is a prerequisite for all further viral gene expression (W.L. Gray, R. P. Baumann, A. T. Robertson, G. B. Caughman, D. J. O'Callaghan, and J. Staczek, Virology 158:79-87, 1987). An EHV-1 IE gene expression vector (pSVIE) in combination with chimeric EHV-1 promoter-chloramphenicol acetyltransferase (CAT) reporter constructs was used in transient transfection assays to charact...
[Virologico-serologic studies in horses with respiratory tract diseases].
Berliner und Munchener tierarztliche Wochenschrift    February 1, 1992   Volume 105, Issue 2 49-52 
Herbst W, Görlich P, Danner K.Of 1081 acute and chronically respiratory diseased as well as clinically normal horses 824 sera and 257 paired serum samples collected 1986 and 1987 were tested for antibodies against several different respiratory viruses such as influenza virus A/equi 1 and 2 (Influenza 1 a. 2), equine herpesvirus type 1/4 (EHV 1/4), mammalian reovirus type 1-3 (Reovirus 1-3), equine rhinovirus type 1 (ERV 1), equine adenovirus type 1 (EAdV 1), and equine arteritis virus (EAV). The investigations resulted in an antibody prevalence of 57.2% (Influenza 1), 59.5% (Influenza 2), 81.5% (EHV 1/4), 50.3% (Reovirus 1...
1 26 27 28 29 30 38